Intravenous beta2-agonists versus intravenous aminophylline for acute asthma

• Author(s) / Creator(s)

  • Travers AH
  • Rowe BH
  • Milan SJ
  • Camargo Jr CA
  • Jones AP

• Date created

  2012

• Subjects / Keywords

  • Acute Disease
  • Adrenergic beta-2 Receptor Agonists/administration & dosage*
  • Aminophylline/administration & dosage*
  • Asthma/drug therapy*
  • Administration, Inhalation
  • Anti-Asthmatic Agents/adverse effects
  • Injections, Intravenous
  • Emergencies
  • Adrenergic beta-2 Receptor Agonists/adverse effects
  • Randomized Controlled Trials as Topic
  • Bronchodilator Agents/adverse effects
  • Anti-Asthmatic Agents/administration & dosage*
  • Length of Stay
  • Bronchodilator Agents/administration & dosage*
  • Heart Rate/drug effects
  • Child
  • Adults
  • Aminophylline/adverse effects
  • Humans

• Type of Item

  Review

• DOI

  https://doi.org/10.7939/R38S4JS0Q

• License

  Copyright © 2012 The Cochrane Collaboration. Published by JohnWiley & Sons, Ltd. This review is published as a Cochrane Review in the Cochrane Database of Systematic Reviews 2012, Issue 12. Cochrane Reviews are regularly updated as new evidence emerges and in response to comments and criticisms, and the Cochrane Database of Systematic Reviews should be consulted for the most recent version of the Review.